You are here: All Products  > CMS Acquires JAK1 Inhibitor from Incyte for Autoimmune/Dermatology Diseases

CMS Acquires JAK1 Inhibitor from Incyte for Autoimmune/Dermatology Diseases

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products